Search

everythinglearnresearchcommunity

for

Search:↓

Chick embryo extract helps rat hair follicle stem cells potentially turn into Schwann cells, important for the nervous system.

Trichoscopy helps accurately diagnose Netherton syndrome, often mistaken for atopic dermatitis.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Cellular senescence can both hinder and promote hair growth, suggesting new ways to treat hair loss.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Cold Atmospheric Microwave Plasma (CAMP) helps hair cells grow and could potentially treat hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Rosacea may be linked to gut and brain issues, not just a skin problem.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Heavy ion radiation has a more severe and long-lasting effect on mouse intestinal metabolites than gamma radiation.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.